Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Optimal Interval for Detection of Molecular Relapse after Stop of Tyrosine Kinase Inhibitor (TKI) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Caliculated By Kinetics of BCR-ABL Transcripts

Koichi Miyamura, MD, Masahide Osaki, MD, Tatsunori Goto, MD PhD, Takanobu Morishita, MD PhD, Yukiyasu Ozawa, MD PhD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-141480

Published: 2020

Journal Articles

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

Jeong Hui Kim, Yasuhiko Harada, MD PhD, Yuichi Ishikawa, MD PhD, Naomi Kawashima, MD PhD, Marie Nakashima, MD, Yoko Ushijima, MD PhD, Takahiro Nishiyama, MD PhD, Tatsunori Goto, MD PhD, Nobuaki Fukushima, MD PhD, Rika Kihara, MD PhD, Tomohiro Kajiguchi, MD PhD, Koichi Watamoto, MD PhD, Akio Kohno, MD PhD, Kunio Kitamura, MD PhD, Yukiyasu Ozawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2019) 134 (Supplement_1): 1418.

https://doi.org/10.1182/blood-2019-127610

Published: 2019

Journal Articles

The Prediction of Clinical Outcome By Controlling Nutrition Status (CONUT) before Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Malignancies

Hiroaki Araie, Tomoe Ichiki, MD, Motohito Okabe, MD, Yuka Kawaguchi, MD, Yoonha Lee, Marie Ohbiki, MD, Masahide Osaki, MD, Miyo Goto, MD, Takahiko Sato, MD, Tatsunori Goto, MD PhD, Takanobu Morishita, MD, PhD, Yukiyasu Ozawa, Koichi Miyamura, MD PhD

Blood (2018) 132 (Supplement 1): 2100.

https://doi.org/10.1182/blood-2018-99-111615

Published: 2018

Journal Articles

The Synergistic T-Cell Signal By CD79A/CD40 Costimulatory Endodomain Enhances CD19 Chimeric Antigen Receptor T-Cell Proliferation and Survival

Jakrawadee Julamanee, MD, Seitaro Terakura, MD PhD, Reona Sakemura, MD PhD, Kotaro Miyao, MD, Shingo Okuno, MD, Sonoko Kamoshita, MD, Erina Takagi, MD, Daisuke Koyama, MD, Tatsunori Goto, MD PhD, Ryo Hanajiri, MD PhD, Tetsuya Nishida, MD PhD, Makoto Murata, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2017) 130 (Supplement 1): 2061.

https://doi.org/10.1182/blood.V130.Suppl_1.2061.2061

Published: 2017

Journal Articles

Quantitative Assessment of TCR Repertoire and Allo-Reactivity of Human Acute Gvhd Tissue-Infiltrating T Cells

Daisuke Koyama, MD, Makoto Murata, MD PhD, Ryo Hanajiri, MD PhD, Shingo Okuno, MD, Sonoko Kamoshita, MD, Erina Takagi, MD, Jakrawadee Julamanee, MD, Kotaro Miyao, MD, Reona Sakemura, MD PhD, Tatsunori Goto, MD PhD, Seitaro Terakura, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2017) 130 (Supplement 1): 1982.

https://doi.org/10.1182/blood.V130.Suppl_1.1982.1982

Published: 2017

NARROW

Optimal Interval for Detection of Molecular Relapse after Stop of Tyrosine Kinase Inhibitor (TKI) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Caliculated By Kinetics of BCR-ABL Transcripts

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

The Prediction of Clinical Outcome By Controlling Nutrition Status (CONUT) before Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Malignancies

The Synergistic T-Cell Signal By CD79A/CD40 Costimulatory Endodomain Enhances CD19 Chimeric Antigen Receptor T-Cell Proliferation and Survival

Quantitative Assessment of TCR Repertoire and Allo-Reactivity of Human Acute Gvhd Tissue-Infiltrating T Cells

Email alerts

ASH Publications

American Society of Hematology

Optimal Interval for Detection of Molecular Relapse after Stop of Tyrosine Kinase Inhibitor (TKI) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Caliculated By Kinetics of BCR-ABL Transcripts

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

The Prediction of Clinical Outcome By Controlling Nutrition Status (CONUT) before Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Malignancies

The Synergistic T-Cell Signal By CD79A/CD40 Costimulatory Endodomain Enhances CD19 Chimeric Antigen Receptor T-Cell Proliferation and Survival

Quantitative Assessment of TCR Repertoire and Allo-Reactivity of Human Acute Gvhd Tissue-Infiltrating T Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only